Siegfried to Enhance CDMO Services with New Acquisition
Siegfried has announced the acquisition of a new site that specialises in early-phase development and manufacturing services. The site, staffed by an experienced team of over…
Siegfried has announced the acquisition of a new site that specialises in early-phase development and manufacturing services. The site, staffed by an experienced team of over…
Essential Pharma has entered into a strategic agreement with AGC Biologics for the production of Hu14.18, a humanized monoclonal antibody. This antibody is currently under development…
Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry, is making a substantial investment in its drug…
Charles River Laboratories, a global provider of products and services to accelerate the research, drug discovery, and drug development process, has announced a new program…
Asgard Therapeutics, a biotech company specialising in in vivo direct cell reprogramming for cancer immunotherapy, has announced its selection of Exothera S.A. for the process…
Corealis Pharma Inc., a trusted name in the world of Contract Research and Development Organizations (CRO/CDMOs), today inaugurates its expanded facilities in Laval’s Biotech City.…
Kyowa Kirin Inc. has announced plans to invest up to $530 million in a new manufacturing facility in Sanford, North Carolina. The 171,700-square-foot, two-reactor facility will…
ReiThera, a contract manufacturing organisation (CDMO), has announced the appointment of Stefano Colloca as its new Chief Executive Officer. The announcement was made on 6th…
AGC Biologics has completed a new manufacturing building at its Copenhagen campus. This expansion doubles the site’s single-use bioreactor capacity for mammalian services, enabling it to…
CordenPharma, a global CDMO specialising in the manufacture of Drug Substances (APIs) for complex modalities, and Certest, a Spanish company focused on developing new products…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.